Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Immunol.

Sec. Multiple Sclerosis and Neuroimmunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1646740

Bidirectional Crosstalk Between Microglia and Serotonin Signaling in Neuroinflammation and CNS Disorders

Provisionally accepted
YANGCHEN  ZHENGYANGCHEN ZHENG1,2,3LIMIN  XULIMIN XU1,2,3*
  • 1School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai 200093 China, 上海市, China
  • 2University of Shanghai for Science and Technology, Shanghai, China
  • 3Shanghai Pudong New Area Gongli Hospital, Shanghai, China

The final, formatted version of the article will be published soon.

Neuroinflammatory processes are increasingly recognized as central to the pathophysiology of diverse central nervous system (CNS) disorders, including major depressive disorder (MDD), Alzheimer's disease (AD), and Parkinson's disease (PD). Microglia, the resident immune effector cells of the CNS, are key regulators of neuroimmune responses and engage in bidirectional communication with the serotonergic system. Activation of microglia toward a pro-inflammatory phenotype can disrupt serotonergic neurotransmission by altering the expression and function of the serotonin transporter (SERT) and modulating downstream 5-HT receptor signaling pathways. Conversely, serotonergic neurotransmission-mediated through receptor subtypes such as 5-HT1A, 5-HT2A/2B, and 5-HT7-can regulate microglial phenotypic polarization and cytokine production, thereby influencing the inflammatory milieu and CNS homeostasis. This review synthesizes current evidence on the dynamic interplay between microglial activation states and serotonergic signaling, emphasizing their mutual contributions to disease onset and progression. Furthermore, we examine the therapeutic potential of targeting this neuroimmune interface using pharmacological strategies, including selective serotonin reuptake inhibitors (SSRIs), anti-inflammatory agents, and receptor-specific ligands. Clarifying this bidirectional crosstalk may inform the development of innovative interventions for neuroinflammation-associated neuropsychiatric and neurodegenerative disorders.

Keywords: microglial polarization, serotonin (5-HT), Serotonin transporter (SERT), Neuroinflammation, neuropsychiatric disorders

Received: 13 Jun 2025; Accepted: 31 Jul 2025.

Copyright: © 2025 ZHENG and XU. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: LIMIN XU, School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai 200093 China, 上海市, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.